4.7 Article

Combined acute hyperglycemic and hyperinsulinemic clamp induced profibrotic and proinflammatory responses in the kidney

Journal

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
Volume 306, Issue 3, Pages C202-C211

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpcell.00144.2013

Keywords

hyperglycemia; hyperinsulinemia; renal fibrosis; TGF-beta; mTOR; laminin

Funding

  1. National Institutes of Health (NIH) [DK-077295, RC2 AG-036613]
  2. VA Merit Review Program and American Diabetes Association
  3. Juvenile Diabetes Research Foundation and the National Kidney Foundation of South and Central Texas
  4. VA Senior Research Career Scientist Award [NIH-R01 (DK-050190)]

Ask authors/readers for more resources

Increase in matrix protein content in the kidney is a cardinal feature of diabetic kidney disease. While renal matrix protein content is increased by chronic hyperglycemia, whether it is regulated by acute elevation of glucose and insulin has not been addressed. In this study, we aimed to evaluate whether short duration of combined hyperglycemia and hyperinsulinemia, mimicking the metabolic environment of prediabetes and early type 2 diabetes, induces kidney injury. Normal rats were subjected to either saline infusion (control, n = 4) or 7 h of combined hyperglycemic-hyperinsulinemic clamp (HG + HI clamp; n = 6). During the clamp, plasma glucose and plasma insulin were maintained at about 350 mg/dl and 16 ng/ml, respectively. HG + HI clamp increased the expression of renal cortical transforming growth factor-beta (TGF-alpha) and renal matrix proteins, laminin and fibronectin. This was associated with the activation of SMAD3, Akt, mammalian target of rapamycin (mTOR) complexes, and ERK signaling pathways and their downstream target events in the initiation and elongation phases of mRNA translation, an important step in protein synthesis. Additionally, HG + HI clamp provoked renal inflammation as shown by the activation of Toll-like receptor 4 (TLR4) and infiltration of CD68-positive monocytes. Urinary F2t isoprostane excretion, an index of renal oxidant stress, was increased in the HG + HI clamp rats. We conclude that even a short duration of hyperglycemia and hyperinsulinemia contributes to activation of pathways that regulate matrix protein synthesis, inflammation, and oxidative stress in the kidney. This finding could have implications for the control of short-term rises in blood glucose in diabetic individuals at risk of developing kidney disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Endocrinology & Metabolism

Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes

Marco Gallo, Giouanna Muscogiuri, Francesco Felicetti, Antongiulio Faggiano, Francesco Trimarchi, Emanuela Arvat, Riccardo Vigneri, Annamaria Colao

METABOLISM-CLINICAL AND EXPERIMENTAL (2018)

Editorial Material Medicine, General & Internal

Gasping for a Diagnosis

Kristin D'Silva, Sarah Brown, Gary M. Hunninghake, Marina Vivero, Joseph Loscalzo

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Rheumatology

Clinical characteristics and renal prognosis associated with interstitial fibrosis and tubular atrophy (IFTA) and vascular injury in lupus nephritis biopsies

Cianna Leatherwood, Cameron B. Speyer, Candace H. Feldman, Kristin D'Silva, Jose A. Gomez-Puerta, Paul J. Hoover, Sushrut S. Waikar, Gearoid M. McMahon, Helmut G. Rennke, Karen H. Costenbader

SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)

Editorial Material Medicine, General & Internal

A Rapid Change in Pressure

Caren G. Solomon

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Rheumatology

Using electronic visits (E-visits) to achieve goal serum urate levels in patients with gout in a rheumatology practice: A pilot study

Chio Yokose, April Jorge, Kristin D'Silva, Naomi Serling-Boyd, Mark Matza, Mazen Nasrallah, Sarah Keller, Amar Oza, Hyon Choi, Marcy B. Bolster, Deborah Collier

SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)

Article Rheumatology

Renal deposits of complement factors as predictors of end-stage renal disease and death in patients with lupus nephritis

Jacob J. E. Koopman, Helmut G. Rennke, Cianna Leatherwood, Cameron B. Speyer, Kristin D'Silva, Gearoid M. McMahon, Sushrut S. Waikar, Karen H. Costenbader

RHEUMATOLOGY (2020)

Article Rheumatology

Hypouricemia and Mortality Risk in the US General Population

Kristin M. D'Silva, Chio Yokose, Na Lu, Natalie McCormick, Hwajeong Lee, Yuqing Zhang, Hyon K. Choi

Summary: The study found no long-term excess mortality risk among American women with SU levels as low as <3 mg/dl, but observed a 28% higher mortality risk in men with SU levels <4 mg/dl. This suggests a potential causal relationship between hypouricemia and mortality in men, particularly from diabetes mellitus.

ARTHRITIS CARE & RESEARCH (2021)

Article Rheumatology

COVID-19 Outcomes in Patients With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A US Multicenter, Comparative Cohort Study

Kristin M. D'Silva, April Jorge, Andrew Cohen, Natalie McCormick, Yuqing Zhang, Zachary S. Wallace, Hyon K. Choi

Summary: The study found that COVID-19 patients with systemic autoimmune rheumatic diseases may have a higher risk of hospitalization, ICU admission, acute renal failure, and venous thromboembolism compared to those without systemic ARDs. These risks may be largely influenced by comorbidities, except for the risk of venous thromboembolism.

ARTHRITIS & RHEUMATOLOGY (2021)

Article Oncology

Outcomes of Patients With Interstitial Lung Disease Receiving Programmed Cell Death 1 Inhibitors: A Retrospective Case Series

Ioana A. Dobre, Angela J. Frank, Kristin M. D'Silva, David C. Christiani, Daniel Okin, Amita Sharma, Sydney B. Montesi

Summary: This study found that patients with ILD receiving PD-1 inhibitors more frequently died from cancer-related causes than from ILD. Further research is needed to determine the safety of ICIs in patients with ILD and if ILD subtype may help to refine ICI-associated risks.

CLINICAL LUNG CANCER (2021)

Article Rheumatology

COVID-19 and Disease-Modifying Anti-rheumatic Drugs

Kristin M. D'Silva, Zachary S. Wallace

Summary: Baseline glucocorticoid use is associated with severe COVID-19 outcomes in autoimmune disease patients, but DMARDs categories do not appear to increase risk. Randomized clinical trials show glucocorticoids reduce mortality in severe COVID-19, while other agents like baricitinib may improve outcomes in certain populations. More research is needed to guide DMARD management in autoimmune disease patients during the pandemic and their role in COVID-19 treatment.

CURRENT RHEUMATOLOGY REPORTS (2021)

Article Health Care Sciences & Services

Secular Trends in the Pharmacologic Treatment of Osteoporosis and Malignancy-Related Bone Disease from 2009 to 2020

Sara Jane Cromer, Kristin M. D'Silva, Elaine W. Yu, Joan Landon, Rishi J. Desai, Seoyoung C. Kim

Summary: The study found that the use of denosumab has surpassed all other bone-directed therapies over the past decade, especially since its approval in 2010. The use of denosumab also showed increasing trends among patients with osteoporosis, malignancies, and recent fractures. However, it is noteworthy that the proportion of using any bone-directed therapy after fractures is low and has declined over time.

JOURNAL OF GENERAL INTERNAL MEDICINE (2022)

Article Rheumatology

Rituximab for interstitial pneumonia with autoimmune features at two medical centres

Kristin M. D'Silva, Iazsmin Bauer Ventura, Marcy B. Bolster, Flavia Castelino, Amita Sharma, Brent P. Little, Ayodeji Adegunsoye, Mary E. Strek, Hyon Choi, Sydney B. Montesi

Summary: A multicentre observational study examined the use of rituximab (RTX) in interstitial pneumonia with autoimmune features (IPAF) patients. The majority of IPAF patients treated with RTX at two medical centres demonstrated improvement or stability at 1 year, calling for prospective studies to determine the risks, benefits and cost effectiveness of RTX in IPAF.

RHEUMATOLOGY ADVANCES IN PRACTICE (2021)

Article Respiratory System

Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody

A. Sclafani, K. M. D'Silva, B. P. Little, E. M. Miloslavsky, J. J. Locascio, A. Sharma, S. B. Montesi

RESPIRATORY RESEARCH (2019)

Review Food Science & Technology

Gut: A key player in the pathogenesis of type 2 diabetes?

Giovanna Muscogiuri, Giancarlo Balercia, Luigi Barrea, Angelo Cignarelli, Francesco Giorgino, Jens J. Holst, Daniela Laudisio, Francesco Orio, Giacomo Tirabassi, Annamaria Colao

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2018)

Article Endocrinology & Metabolism

Long-term safety of long-acting octreotide in patients with diabetic retinopathy: results of pooled data from 2 randomized, double-blind, placebo-controlled phase 3 studies

Rosario Pivonello, Giovanna Muscogiuri, Geoffrey Holder, Michaela Paul, Severine Sarp, Anastasia Lesogor, Pierre Jordaan, Johannes Eisinger, Annamaria Colao

ENDOCRINE (2018)

No Data Available